Treatment-refractory schizophrenia is common. Refinements in pharmacologic and psychosocial treatments of schizophrenia offer the expectation of superior outcomes for this disadvantaged patient group. This article critically reviews those articles that were published during the year 2000 that address this treatment-refractory population.
|Original language||English (US)|
|Number of pages||8|
|Journal||Current psychiatry reports|
|State||Published - Oct 2001|
ASJC Scopus subject areas
- Psychiatry and Mental health